Beam Therapeutics Inc. - COM (BEAM)

Historical Portfolio Holders from Q1 2020 to Q2 2024

All holders as of March 31, 2024
Q1 2024
Type / Class
Equity / COM
Shares, excl. options Q1 2024
65.6 M
Holdings value Q1 2024
$2.17 B
Value change Q1 2024
+$41.7 M
Grand Portfolio weight change Q1 2024
+0%
Number of holders
209
Number of buys Q1 2024
6
Number of sells Q1 2024
-4
Average buys Q1 2024 %
+0%
Average sells Q1 2024 %
0%
CUSIP
07373V105
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q2 107 K $2.5 M +$117 K $23.43 10
2024 Q1 65.9 M $2.18 B +$41.7 M $33.04 211
2023 Q4 68.9 M $1.88 B +$54.7 M $27.22 185
2023 Q3 67.1 M $1.61 B +$72.5 M $24.05 189
2023 Q2 63.6 M $2.03 B +$115 M $31.93 188
2023 Q1 60.3 M $1.85 B +$135 M $30.62 204
2022 Q4 55.8 M $2.18 B +$43.3 M $39.11 203
2022 Q3 54.5 M $2.6 B -$181 K $47.64 213
2022 Q2 54.5 M $2.08 B +$183 M $38.71 184
2022 Q1 49.2 M $2.82 B +$202 M $57.30 228
2021 Q4 45.5 M $3.63 B -$38.9 M $79.69 227
2021 Q3 45.2 M $3.93 B -$59.5 M $87.01 225
2021 Q2 45.4 M $5.85 B +$330 M $128.71 230
2021 Q1 42.8 M $3.42 B +$467 M $80.04 206
2020 Q4 36.9 M $3.01 B +$627 M $81.64 153
2020 Q3 29.5 M $727 M +$39.4 M $24.62 80
2020 Q2 27.7 M $776 M +$34.1 M $28.00 70
2020 Q1 26.9 M $484 M +$484 M $18.00 60